These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19760772)

  • 1. Treatment results of the Ewing sarcoma of bone and prognostic factors.
    Sari N; Toğral G; Cetindağ MF; Güngör BS; Ilhan IE
    Pediatr Blood Cancer; 2010 Jan; 54(1):19-24. PubMed ID: 19760772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].
    Ullmann C; Beck JD; Holter W; Petsch S; Dunst J; Sauer R; Grabenbauer GG
    Strahlenther Onkol; 2008 Mar; 184(3):137-44. PubMed ID: 18330509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES).
    Haeusler J; Ranft A; Boelling T; Gosheger G; Braun-Munzinger G; Vieth V; Burdach S; van den Berg H; Juergens H; Dirksen U
    Cancer; 2010 Jan; 116(2):443-50. PubMed ID: 19924786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after recurrence of Ewing's sarcoma family of tumors.
    Barker LM; Pendergrass TW; Sanders JE; Hawkins DS
    J Clin Oncol; 2005 Jul; 23(19):4354-62. PubMed ID: 15781881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
    Krasin MJ; Davidoff AM; Rodriguez-Galindo C; Billups CA; Fuller CE; Neel MD; Merchant TE
    Cancer; 2005 Jul; 104(2):367-73. PubMed ID: 15948159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.
    Shankar AG; Ashley S; Craft AW; Pinkerton CR
    Med Pediatr Oncol; 2003 Mar; 40(3):141-7. PubMed ID: 12518341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H;
    J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
    Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
    J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
    J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.
    Miser JS; Goldsby RE; Chen Z; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore SG; Rausen AR; Vietti TJ; Grier HE
    Pediatr Blood Cancer; 2007 Dec; 49(7):894-900. PubMed ID: 17584910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
    Yock TI; Krailo M; Fryer CJ; Donaldson SS; Miser JS; Chen Z; Bernstein M; Laurie F; Gebhardt MC; Grier HE; Tarbell NJ;
    J Clin Oncol; 2006 Aug; 24(24):3838-43. PubMed ID: 16921035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
    La TH; Meyers PA; Wexler LH; Alektiar KM; Healey JH; Laquaglia MP; Boland PJ; Wolden SL
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):544-50. PubMed ID: 16198063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
    Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
    J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-term review of the treatment of patients with Ewing's sarcoma in one institution.
    Sluga M; Windhager R; Lang S; Heinzl H; Krepler P; Mittermayer F; Dominkus M; Zoubek A; Kotz R
    Eur J Surg Oncol; 2001 Sep; 27(6):569-73. PubMed ID: 11520091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
    Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
    J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-- preliminary results].
    Paulussen M; Ahrens S; Braun-Munzinger G; Craft AW; Dockhorn-Dworniczak B; Dörffel W; Dunst J; Fröhlich B; Göbel U; Häussler M; Klingebiel T; Koscielniak E; Mittler U; Rübe C; Winkelmann W; Voûte PA; Zoubek A; Jürgens H
    Klin Padiatr; 1999; 211(4):276-83. PubMed ID: 10472562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
    Bacci G; Longhi A; Ferrari S; Mercuri M; Barbieri E; Bertoni F; Bacchini P; Picci P
    Eur J Surg Oncol; 2006 Nov; 32(9):974-9. PubMed ID: 16621429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.
    Bacci G; Longhi A; Ferrari S; Mercuri M; Versari M; Bertoni F
    Acta Oncol; 2006; 45(4):469-75. PubMed ID: 16760184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry.
    Ladenstein R; Lasset C; Pinkerton R; Zucker JM; Peters C; Burdach S; Pardo N; Dallorso S; Coze C
    Bone Marrow Transplant; 1995 May; 15(5):697-705. PubMed ID: 7670398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.
    Burdach S; Meyer-Bahlburg A; Laws HJ; Haase R; van Kaik B; Metzner B; Wawer A; Finke R; Göbel U; Haerting J; Pape H; Gadner H; Dunst J; Juergens H
    J Clin Oncol; 2003 Aug; 21(16):3072-8. PubMed ID: 12915596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.